Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Aug 25, 2016 at 8:45 AM EDT

Major Pharma Short Interest Faces Significant Drop

The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Aug 25, 2016 at 8:40 AM EDT

Short Sellers Increase Bets in Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across…

Jon C. Ogg | Aug 24, 2016 at 12:20 PM EDT

Concerns Persist on Mylan EpiPen Price Gouging — or Do They?

Mylan is under fire for price gouging on its EpiPen. There has been some concern that this was a serious…

Jon C. Ogg | Aug 24, 2016 at 10:25 AM EDT

How Analysts and Investors Are Chasing Clovis Higher and Higher, All Over Again

Clovis Oncology shares saw a massive gain on Tuesday, on the heels of news that the FDA had granted it…

Paul Ausick | Aug 24, 2016 at 10:10 AM EDT

Federal Funding Approved for Rapid Zika Virus Test

Medical diagnostics maker OraSure Technologies said Tuesday night that it has been awarded a more than $16 million contract to…

Chris Lange | Aug 23, 2016 at 4:08 PM EDT

How Clovis Scored Big on a Milestone FDA Approval

Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares climb late Tuesday after the company announced a key U.S. Food…

Douglas A. McIntyre | Aug 23, 2016 at 9:15 AM EDT

Best Ways to Prevent Mosquito Bites — CDC

As fears that the mosquito-born Zika virus continue to spread, the CDC has several rules to cut the chance of…

Chris Lange | Aug 22, 2016 at 10:25 AM EDT

Valeant Gains Momentum With New CFO Appointment

Shares of Valeant Pharmaceuticals saw a handy gain in Monday’s session after the company announced that it has appointed a…

Paul Ausick | Aug 22, 2016 at 7:55 AM EDT

Pfizer Pays a Big Premium for Medivation

In one of the longest running bidding wars in recent times, Pfizer has finally reeled in cancer-drug maker Medivation.

Douglas A. McIntyre | Aug 21, 2016 at 9:05 AM EDT

Zika Active in 56 Countries and States

The latest data from the U.S. Centers for Disease Control and Prevention (CDC) show that the Zika virus is actively…

Douglas A. McIntyre | Aug 20, 2016 at 9:05 AM EDT

Zika Comes From Uganda

As the Zika virus disease threatens to spread north along the Florida Coast, stories in the news media often make…

Jon C. Ogg | Aug 18, 2016 at 12:50 PM EDT

How Much Medivation Can Really Fetch in a Buyout

Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have…

Chris Lange | Aug 18, 2016 at 11:50 AM EDT

Thursday’s Top Health Care Stocks Punishing Investors

On Thursday, a few companies in the biotech and pharmaceutical industries made substantial runs. In this case it was all…

Chris Lange | Aug 17, 2016 at 10:35 AM EDT

Why Valeant Got Its First Big Analyst Upgrade of 2016

Although some analysts have become less negative and upgraded to a more neutral view on Valeant Pharmaceuticals, Morgan Stanley's is…

Chris Lange | Aug 16, 2016 at 10:55 AM EDT

Tuesday’s Top Health Care Movers

On Tuesday, a few biotech companies made substantial runs, either up and down, due to the results of FDA approvals,…

1 … 197 198 199 200 201 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Major Pharma Short Interest Faces Significant Drop

Short Sellers Increase Bets in Major Biotechs

Concerns Persist on Mylan EpiPen Price Gouging — or Do They?

How Analysts and Investors Are Chasing Clovis Higher and Higher, All Over Again

Federal Funding Approved for Rapid Zika Virus Test

How Clovis Scored Big on a Milestone FDA Approval

Best Ways to Prevent Mosquito Bites — CDC

Valeant Gains Momentum With New CFO Appointment

Pfizer Pays a Big Premium for Medivation

Zika Active in 56 Countries and States

Zika Comes From Uganda

How Much Medivation Can Really Fetch in a Buyout

Thursday’s Top Health Care Stocks Punishing Investors

Why Valeant Got Its First Big Analyst Upgrade of 2016

Tuesday’s Top Health Care Movers

5 Goldman Sachs Top Picks for May Are Safe, Pay Dividends With Double-Digit Upside

What Happens to Palantir If Alex Karp Steps Down?

Oracle Stock’s Breakout Is Real and the Long-Term AI Infrastructure Case Is Only Getting Stronger

A $750,000 Portfolio That Quietly Pays You $41,700 a Year

Ari Taublieb's Retirement Warning: You've Hit Your Number, But Psychology May Stop You Cold

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, American Eagle Outfitters, GlobalFoundries, IAC, Merck, Palantir Technologies, Reddit, and More

5 Goldman Sachs Top Picks for May Are Safe, Pay Dividends With Double-Digit Upside

Health and Healthcare Articles

All Health and Healthcare Articles

Major Pharma Short Interest Faces Significant Drop

Short Sellers Increase Bets in Major Biotechs

Concerns Persist on Mylan EpiPen Price Gouging — or Do They?

How Analysts and Investors Are Chasing Clovis Higher and Higher, All Over Again

Federal Funding Approved for Rapid Zika Virus Test

How Clovis Scored Big on a Milestone FDA Approval

Best Ways to Prevent Mosquito Bites — CDC

Valeant Gains Momentum With New CFO Appointment

Pfizer Pays a Big Premium for Medivation

Zika Active in 56 Countries and States

Zika Comes From Uganda

How Much Medivation Can Really Fetch in a Buyout

Thursday’s Top Health Care Stocks Punishing Investors

Why Valeant Got Its First Big Analyst Upgrade of 2016

Tuesday’s Top Health Care Movers

5 Goldman Sachs Top Picks for May Are Safe, Pay Dividends With Double-Digit Upside

What Happens to Palantir If Alex Karp Steps Down?

Oracle Stock’s Breakout Is Real and the Long-Term AI Infrastructure Case Is Only Getting Stronger

Featured Reads

A $750,000 Portfolio That Quietly Pays You $41,700 a Year

Ari Taublieb's Retirement Warning: You've Hit Your Number, But Psychology May Stop You Cold